UZ Leuven-Investigational Site Number : 0560001
Welcome,         Profile    Billing    Logout  
 4 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Olesen, Gitte
ROCKnrol-1, NCT06143891: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Recruiting
3
260
Europe, Canada, US, RoW
Belumosudil, SAR445761/ KD025, REZUROCK, Placebo, Prednisone, Prednisolone
Sanofi
Chronic Graft Versus Host Disease
09/28
09/28
DEVILLIER, Raynier
ROCKnrol-1, NCT06143891: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Recruiting
3
260
Europe, Canada, US, RoW
Belumosudil, SAR445761/ KD025, REZUROCK, Placebo, Prednisone, Prednisolone
Sanofi
Chronic Graft Versus Host Disease
09/28
09/28
ELIT-AML01, NCT03597321: Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Recruiting
2
124
Europe
prophylactic donor lymphocyte infusion (DLI)
Institut Paoli-Calmettes
Acute Myeloid Leukemia
12/24
12/24
PHOEBUS, NCT05762211: Oral Pooled Fecal Microbiotherapy to Prevent Allogeneic Hematopoietic Cell Transplantation Complications ( Trial)

Recruiting
2
387
Europe
Pooled allogeneic fecal microbiotherapy, MaaT033, Placebo
MaaT Pharma
Transplant Complication
10/26
02/27
FLUCLORIC, NCT05917405: Study Comparing the Efficacy of 2 RIC Regimens (Clofarabine vs Fludarabine) in Adults With AML Eligible to Allo-SCT

Recruiting
2
302
Europe
Fludarabine, Busulfan, ATG, Clofarabine
Nantes University Hospital
Acute Myeloid Leukemia in Remission
09/28
09/28
ReSET-02, NCT05768035 / 2022-002530-14: Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant Cyclophosphamide

Recruiting
1/2
40
Europe
Allogeneic T cell progenitors, cultured ex-vivo, SMART101
Smart Immune SAS, SMART IMMUNE
Hematological Malignancies
07/25
07/26
SIA-CSH, NCT03965429: Immunological Follow-up After Allogeneic Hematopoietic Stem Cell Transplantation

Active, not recruiting
N/A
1020
Europe
Blood samples (additional tubes from care) longitudinal, Blood samples (additional tubes from care) at inclusion
Institut Paoli-Calmettes, INSERM-U1068
Malignant Hemopathy
05/29
05/29
VERCELLINO, Lisa
ROCKnrol-1, NCT06143891: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Recruiting
3
260
Europe, Canada, US, RoW
Belumosudil, SAR445761/ KD025, REZUROCK, Placebo, Prednisone, Prednisolone
Sanofi
Chronic Graft Versus Host Disease
09/28
09/28
BOIARYNA, Liliana
ROCKnrol-1, NCT06143891: A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

Recruiting
3
260
Europe, Canada, US, RoW
Belumosudil, SAR445761/ KD025, REZUROCK, Placebo, Prednisone, Prednisolone
Sanofi
Chronic Graft Versus Host Disease
09/28
09/28

Download Options